Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution

Dr. B. Ekbal explores how Trump’s appointment of anti-science figures to key health positions could shape US healthcare

This latest iteration of Trump’s global trade war can be understood as another strike against Chinese industry

Trump’s mass deportation plan is rapidly expanding beyond US borders, with migrants now detained at Guantánamo Bay and deals being struck with Latin American nations.

In the first installment of an in-depth analysis, Dr. B. Ekbal examines the potential global health impact of Donald Trump’s presidency, drawing parallels to his past healthcare policies

The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives

Following two separate conversations with Mexican and Canadian leaders, Trump delays 25% tariffs on the two countries by one month

US arms suppliers recorded a 29% jump in sales in 2024 and constituted a total share of 42% of the world’s total arms trade in 2023.

Nine countries including South Africa, Namibia, and Chile formed the Hague Group to hold Israel accountable for its crimes

According to a human rights group, Swiss authorities may be preparing to deport Abunimah following his detention on Saturday

Donald Trump’s push to withdraw from the WHO raises budgetary concerns, but signals cautious hope for strengthening Global South voices in the forum

Antimicrobial resistance, a full-fledged global health crisis, is compounded by the devastating impact of war and armed conflicts